Market Place
Sourcing Support
Diakonos Oncology presents Phase I analysis of DOC1021
09 Apr 2025 //
PR NEWSWIRE
Diakonos Oncology Appoints Laura as Chief Medical Officer
18 Nov 2024 //
BUSINESSWIRE
Neurosurgeon Joseph Georges Receives CNS 2024 Research Award
15 Oct 2024 //
BUSINESSWIRE
Diakonos` Vaccine Shows 93% Survival For Glioblastoma Patients
01 Oct 2024 //
BUSINESSWIRE
Diakonos Oncology Closes $11.4M Seed Financing For Dendritic Cell Vaccine Trial
26 Aug 2024 //
BUSINESSWIRE
Diakonos Gets FDA Fast Track For Pancreatic Cancer Vaccine Adds Advisor
15 Jul 2024 //
BUSINESSWIRE
Diakonos Oncology to Present at the Emerging Growth Conference
10 Jun 2024 //
BUSINESSWIRE
Diakonos Oncology CFO Baldor To Provide Update At BIO Convention
03 Jun 2024 //
BUSINESSWIRE
Diakonos Appoints Biotech Veteran Anthony Baldor as Chief Financial Officer
26 Feb 2024 //
BUSINESSWIRE
Diakonos Names Paul Lammers Veteran Senior Executive to its Board of Directors
20 Feb 2024 //
BUSINESSWIRE
Diakonos Oncology Completes Phase 1 Glioblastoma Trial Recruitment
02 Jan 2024 //
BUSINESSWIRE
Diakonos Awarded FDA Fast Track Designation for Dendritic Cell Vaccine
17 Oct 2023 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.